Acute and subacute effects of the selective serotonin–noradrenaline reuptake inhibitor duloxetine on cardiac hERG channels

2013 ◽  
Vol 386 (9) ◽  
pp. 795-804 ◽  
Author(s):  
F. Fischer ◽  
N. Vonderlin ◽  
C. Seyler ◽  
E. Zitron ◽  
B. Schernus ◽  
...  
Keyword(s):  
Reuptake Inhibitor ◽  
Selective Serotonin ◽  
Noradrenaline Reuptake ◽  
Herg Channels ◽  
Noradrenaline Reuptake Inhibitor

Application of PLGA nanoparticles to enhance the action of Duloxetine on microglia in neuropathic pain

2021 ◽  
Author(s):  
Song I Kim ◽  
Juhee Shin ◽  
Quangdon Tran ◽  
Hyewon Park ◽  
Hyeok Hee Kwon ◽  
...  
Keyword(s):  
Neuropathic Pain ◽  
Side Effects ◽  
Reuptake Inhibitor ◽  
Plga Nanoparticles ◽  
Selective Serotonin ◽  
Noradrenaline Reuptake ◽  
Noradrenaline Reuptake Inhibitor

Duloxetine (DLX) is a selective serotonin and noradrenaline reuptake inhibitor (SNRI) used for treatment of pain, but it has been reported to show side effects in 10–20% of patients. Its...

(R)-Sila-venlafaxine: A selective noradrenaline reuptake inhibitor for the treatment of emesis

2006 ◽  
Vol 16 (9) ◽  
pp. 2555-2558 ◽  
Author(s):  
Graham A. Showell ◽  
Matthew J. Barnes ◽  
Jürgen O. Daiss ◽  
John S. Mills ◽  
John G. Montana ◽  
...  
Keyword(s):  
Reuptake Inhibitor ◽  
Noradrenaline Reuptake ◽  
Noradrenaline Reuptake Inhibitor
Sign in / Sign up

Export Citation Format

Share Document